Position in SUPN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$21,301
-$37,056 QoQ
Shares Held
458
-59.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#261
of 331 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIRST HORIZON CORP holds $758,463 across 10 Drug Manufacturers - Specialty & Generic names. SUPN ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,407 | $316,686 | |
| 2 | HLN |
Haleon plc
|
20,921 | $195,192 | |
| 3 | VTRS |
Viatris Inc
|
7,472 | $118,654 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,116 | $37,810 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
330 | $36,609 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
458 | $21,301 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
123 | $20,730 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
21 | $11,378 |
All Filings in SUPN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,301 | 458 | Shares | Defined | 2026-07-20 | |
| 2026-03-31 | $58,357 | 1,129 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $73,307 | 1,475 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $23,464 | 491 | Shares | Defined | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||